(Q37796024)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Gene therapy for dopamine replacement (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Erik Cederfjäll

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Deniz Kirik

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887878%20AND%20SRC:MED&resulttype=core&format=json

Progress in Brain Research

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

221-235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887878%20AND%20SRC:MED&resulttype=core&format=json

Characterization of the catalytic domain of bovine adrenal tyrosine hydroxylase

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-DOPA in the rat, with reference to the involvement of aromatic L-amino acid decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Gene therapy for dopamine replacement in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Dopamine neuron systems in the brain: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Characterization of rat and human tyrosine hydroxylase genes: functional expression of both promoters in neuronal and non-neuronal cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Regulation of DOPA decarboxylase activity in brain of living rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Tyrosine hydroxylase phosphorylation: regulation and consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Results from a phase I safety trial of hAADC gene therapy for Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

The metal requirement of rat tyrosine hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Complete coding sequence of rat tyrosine hydroxylase mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Recombinant human tyrosine hydroxylase isozymes. Reconstitution with iron and inhibitory effect of other metal ions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

pH-dependent release of catecholamines from tyrosine hydroxylase and the effect of phosphorylation of Ser-40

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: regulated release of dopamine in mouse anterior pituitary AtT-20 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Exogeneous expression of L-dopa and dopamine in various cell lines following transfer of rat and human tyrosine hydroxylase cDNA: grafting in an animal model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Demonstration of L-dopa decarboxylating neurons specific to human striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Behavioral effects and gene delivery in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Decarboxylation of L-dopa by cultured mouse astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Regulation of dopamine production by genetically modified primary fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Dopa-decarboxylation in the striata of rats with unilateral substantia nigra lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Mechanism of Transport and Storage of Neurotransmitter

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTPcyclohydrolase I with tyrosine hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Positron emission tomography imaging demonstrates correlation between behavioral recovery and correction of dopamine neurotransmission after gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Tetrahydrobiopterin in Striatum: Localization in Dopamine Nerve Terminals and Role in Catecholamine Synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Inhibition of guinea-pig brain tyrosine hydroxylase by catechols and biopterin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

L-Dopa and dopamine-producing gene cassettes for gene therapy approaches to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Effects of phosphorylation on binding of catecholamines to tyrosine hydroxylase: specificity and thermodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behaviora

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Correction of a Rat Model of Parkinson's Disease by Coexpression of Tyrosine Hydroxylase and Aromatic Amino Acid Decarboxylase from a Helper Virus-Free Herpes Simplex Virus Type 1 Vector

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Aromatic L-amino-acid decarboxylase (DOPA decarboxylase) gene expression in dopaminergic and serotoninergic cells of the rat brainstem

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Sepiapterin reductase expression is increased in Parkinson's disease brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Tetrahydrobiopterin-dependent functional recovery in 6-hydroxydopamine-treated rats by intracerebral grafting of fibroblasts transfected with tyrosine hydroxylase cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Bovine Adrenal Tyrosine Hydroxylase: Comparative Study of Native and Proteolyzed Enzyme, and Their Interaction with Anions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Lack of regulation of aromatic L-amino acid decarboxylase in intact bovine chromaffin cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

Corelease of dopamine and serotonin from striatal dopamine terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984012-9

7 January 2021

10.1016/S0079-6123(10)84012-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference